Elanco Animal Health (ELAN) Business Metric Overview - Stocknear

Elanco Animal Health

NYSE: ELAN · Real-Time Price · USD
18.43
-0.35 (-1.86%)
At close: Sep 12, 2025, 11:14 AM

Elanco Animal Health Revenue Breakdown

Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020
Cattle Revenue 268M 272M 510M 253M 257M 244M 249M 242M 210M 248M 222M 227M 248M 17M 15M 21M 27M 19M 64.1M 16.1M
Cattle Revenue Growth -1.47% -46.67% +101.58% -1.56% +5.33% -2.01% +2.89% +15.24% -15.32% +11.71% -2.20% -8.47% +1358.82% +13.33% -28.57% -22.22% +42.11% -70.36% +298.14% n/a
Contract Manufacturing Revenue 15M 12M 22M 14M 11M 10M 9M 12M 12M 9M 13M 12M 12M 569M 604M 583M 567M 578M n/a n/a
Contract Manufacturing Revenue Growth +25.00% -45.45% +57.14% +27.27% +10.00% +11.11% -25.00% 0.00% +33.33% -30.77% +8.33% 0.00% -97.89% -5.79% +3.60% +2.82% -1.90% n/a n/a n/a
Farm Animal Revenue 583M 546M 1.16B 530M 594M 556M 610M 561M 527M 573M 552M 545M 553M 639M 494M 527M 685M 645M n/a n/a
Farm Animal Revenue Growth +6.78% -53.09% +119.62% -10.77% +6.83% -8.85% +8.73% +6.45% -8.03% +3.80% +1.28% -1.45% -13.46% +29.35% -6.26% -23.07% +6.20% n/a n/a n/a
Pet Health Revenue 643M 635M 1.02B 486M 579M 639M 416M 495M 518M 675M 416M 471M 612M n/a n/a n/a n/a n/a n/a n/a
Pet Health Revenue Growth +1.26% -37.62% +109.47% -16.06% -9.39% +53.61% -15.96% -4.44% -23.26% +62.26% -11.68% -23.04% n/a n/a n/a n/a n/a n/a n/a n/a
Poultry Revenue 215M 189M 411M 188M 198M 197M 220M 184M 178M 183M 187M 176M 174M n/a n/a n/a n/a n/a n/a n/a
Poultry Revenue Growth +13.76% -54.01% +118.62% -5.05% +0.51% -10.45% +19.57% +3.37% -2.73% -2.14% +6.25% +1.15% n/a n/a n/a n/a n/a n/a n/a n/a
Swine Revenue 100M 85M 194M 88M 90M 84M 98M 93M 89M 102M 100M 95M 89M n/a n/a n/a n/a n/a n/a n/a
Swine Revenue Growth +17.65% -56.19% +120.45% -2.22% +7.14% -14.29% +5.38% +4.49% -12.75% +2.00% +5.26% +6.74% n/a n/a n/a n/a n/a n/a n/a n/a

Revenue by Geography

Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018
Non-Us Revenue 648M 639M 545M 543M 641M 674M 574M 589M 557M 714M 553M 638M 703M 610M 624M 698M 709M 633.6M 468.1M 338.2M 357.8M 383.1M 386.6M 347.2M 424.7M 378.9M
Non-Us Revenue Growth +1.41% +17.25% +0.37% -15.29% -4.90% +17.42% -2.55% +5.75% -21.99% +29.11% -13.32% -9.25% +15.25% -2.24% -10.60% -1.55% +11.90% +35.36% +38.41% -5.48% -6.60% -0.91% +11.35% -18.25% +12.09% n/a
United States Revenue 593M 554M 475M 487M 543M 531M 461M 479M 500M 543M 475M 539M 522M 503M 507M 581M 533M 506.1M 421.5M 248.1M 299.9M 388.2M 395M 383.9M 374.6M 382.2M
United States Revenue Growth +7.04% +16.63% -2.46% -10.31% +2.26% +15.18% -3.76% -4.20% -7.92% +14.32% -11.87% +3.26% +3.78% -0.79% -12.74% +9.01% +5.32% +20.07% +69.89% -17.27% -22.75% -1.72% +2.89% +2.48% -1.99% n/a

Operating Expense Breakdown

Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018 Jun 30, 2018 Mar 31, 2018 Dec 31, 2017 Sep 30, 2017 Jun 30, 2017 Mar 31, 2017
Selling, General, and Administrative Revenue 400M 341M 300M 323M 354M 337M 292M 313M 353M 327M 303M 298M 343M 323M 327M 342M 385M 348M 374.1M 277.7M 162.8M 182M 185.9M 192.3M 200.9M 181.1M 185.1M 179M 191.1M 180M 196.8M 194.7M 194.2M 194.2M
Selling, General, and Administrative Revenue Growth +17.30% +13.67% -7.12% -8.76% +5.04% +15.41% -6.71% -11.33% +7.95% +7.92% +1.68% -13.12% +6.19% -1.22% -4.39% -11.17% +10.63% -6.98% +34.71% +70.58% -10.55% -2.10% -3.33% -4.28% +10.93% -2.16% +3.41% -6.33% +6.17% -8.54% +1.08% +0.26% 0.00% n/a
Research and Development Revenue 92M 94M 81M 87M 89M 87M 79M 86M 81M 81M 80M 78M 82M 81M 92M 94M 94M 89M 112.7M 88.1M 59.4M 66.8M 67.3M 69.9M 68.8M 64.1M 61.1M 58.9M 61.4M 65.2M 62M 61.9M 63.95M 63.95M
Research and Development Revenue Growth -2.13% +16.05% -6.90% -2.25% +2.30% +10.13% -8.14% +6.17% 0.00% +1.25% +2.56% -4.88% +1.23% -11.96% -2.13% 0.00% +5.62% -21.03% +27.92% +48.32% -11.08% -0.74% -3.72% +1.60% +7.33% +4.91% +3.74% -4.07% -5.83% +5.16% +0.16% -3.21% 0.00% n/a